实现实际标准化:在韩国开发儿科的临床常用数据元素,并探索它们的临床实用性
Jaeso Cho1, Hee Jeong Yun2, Hyun Woo Kim2
1Department of Pediatrics, Seoul National University Bundang Hospital, Seongnam, South Korea; Department of Pediatrics, Seoul National University College of Medicine, Seoul, South Korea.
Seizure
|February 27, 2026
概括
儿科的常用数据元素 (CDE) 在韩国诊所开发和测试. 这些CDE被证明可用于收集高质量的数据,改善患者护理和研究.
科学领域:
- 神经学 神经学
- 临床数据管理 临床数据管理
- 儿科的研究研究.
背景情况:
- 儿科需要在时间有限的临床环境中有效收集数据.
- 现有的框架可能无法优化,以满足韩国儿科治疗的特定需求.
- 开发标准化数据元素对于研究和临床实践改进至关重要.
研究的目的:
- 开发和评估韩国儿科的共同数据元素 (CDE).
- 评估这些CDE在现实临床环境中的可行性和临床实用性.
- 为时间有限的临床接触量身定制CDE.
主要方法:
- 多中心开发过程,涉及专家讨论和对现有数据的审查.
- 在多个三级医院中对CDE模板进行回顾性和前性测试.
- 通过对儿科患者的潜在应用进行可行性评估.
主要成果:
- 开发了可行的CDE模板,用于捕获儿科的基线和纵向数据.
- 有效地分析了1096名患者的队列,确定了诸如发育迟缓 (33%) 和耐药性 (30%) 等关键特征.
- 通过小组比较和活动期估计 (中位数为8.2-9.5年) 证明了临床效用.
结论:
- 儿科的CDE可在时间有限的临床环境中使用.
- 高质量的数据收集是可以实现的,提高了患者的护理.
- 开发的CDE支持儿童的研究和临床合作.
更多相关视频
相关概念视频
Epilepsy and Seizures: Overview
1.5K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.5K
Seizures: Classification
1.9K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.9K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
392
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
392
Pharmacokinetics in Pediatric Patients: Drug Excretion
338
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
338
Pharmacokinetics in Pediatric Patients: Drug Distribution
387
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
387
Antiepileptic Drugs: Potassium Channel Activators
867
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
867


